{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:32:24Z","timestamp":1790548344127,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12035-017-0496-4","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T07:06:03Z","timestamp":1490771163000},"page":"2403-2419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Rosalba","family":"Siracusa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Paterniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Crupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bruschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Campolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"496_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci 28:57\u201387. doi:\n10.1146\/annurev.neuro.28.061604.135718","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"496_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.25095","volume":"28","author":"D Sulzer","year":"2013","unstructured":"Sulzer D, Surmeier DJ (2013) Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease. Movement disorders : official journal of the Movement Disorder Society 28(1):41\u201350. doi:\n10.1002\/mds.25095","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"issue":"6","key":"496_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909","journal-title":"Neuron"},{"issue":"21","key":"496_CR4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/01.wnl.0000312515.52545.51","volume":"70","author":"C Marras","year":"2008","unstructured":"Marras C, Lang A (2008) Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain. Neurology 70(21):1996\u20132003. doi:\n10.1212\/01.wnl.0000312515.52545.51","journal-title":"Neurology"},{"issue":"4","key":"496_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397. doi:\n10.1016\/S1474-4422(09)70062-6","journal-title":"Lancet Neurol"},{"issue":"10","key":"496_CR6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.mayocp.2016.08.010","volume":"91","author":"SH Mehta","year":"2016","unstructured":"Mehta SH, Tanner CM (2016) Role of neuroinflammation in Parkinson disease: the enigma continues. Mayo Clin Proc 91(10):1328\u20131330. doi:\n10.1016\/j.mayocp.2016.08.010","journal-title":"Mayo Clin Proc"},{"key":"496_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2016.01.046","volume":"616","author":"S Mitra","year":"2016","unstructured":"Mitra S, Ghosh N, Sinha P, Chakrabarti N, Bhattacharyya A (2016) Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Neurosci Lett 616:86\u201392. doi:\n10.1016\/j.neulet.2016.01.046","journal-title":"Neurosci Lett"},{"issue":"4","key":"496_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4161\/oxim.3.4.12809","volume":"3","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Kim C, Lee SJ (2010) Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection. Oxidative Med Cell Longev 3(4):283\u2013287. doi:\n10.4161\/oxim.3.4.12809","journal-title":"Oxidative Med Cell Longev"},{"issue":"2","key":"496_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/mds.26477","volume":"31","author":"M Xilouri","year":"2016","unstructured":"Xilouri M, Brekk OR, Stefanis L (2016) Autophagy and alpha-synuclein: relevance to Parkinson\u2019s disease and related synucleopathies. Movement disorders : official journal of the Movement Disorder Society 31(2):178\u2013192. doi:\n10.1002\/mds.26477","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"issue":"3","key":"496_CR10","doi-asserted-by":"publisher","first-page":"e2000374","DOI":"10.1371\/journal.pbio.2000374","volume":"15","author":"RM Oliveira de","year":"2017","unstructured":"de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szego EM, Martinho R, Munari F, Lazaro DF et al (2017) The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol 15(3):e2000374. doi:\n10.1371\/journal.pbio.2000374","journal-title":"PLoS Biol"},{"key":"496_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.redox.2016.12.032","volume":"11","author":"M Redmann","year":"2017","unstructured":"Redmann M, Wani WY, Volpicelli-Daley L, Darley-Usmar V, Zhang J (2017) Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils. Redox Biol 11:429\u2013437. doi:\n10.1016\/j.redox.2016.12.032","journal-title":"Redox Biol"},{"issue":"4","key":"496_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","volume":"6","author":"B Levine","year":"2004","unstructured":"Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6(4):463\u2013477","journal-title":"Dev Cell"},{"issue":"5","key":"496_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nn.3365","volume":"16","author":"C Wang","year":"2013","unstructured":"Wang C, Liang CC, Bian ZC, Zhu Y, Guan JL (2013) FIP200 is required for maintenance and differentiation of postnatal neural stem cells. Nat Neurosci 16(5):532\u2013542. doi:\n10.1038\/nn.3365","journal-title":"Nat Neurosci"},{"issue":"9","key":"496_CR14","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.bbamcr.2009.01.016","volume":"1793","author":"Z Yue","year":"2009","unstructured":"Yue Z, Friedman L, Komatsu M, Tanaka K (2009) The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta 1793(9):1496\u20131507. doi:\n10.1016\/j.bbamcr.2009.01.016","journal-title":"Biochim Biophys Acta"},{"key":"496_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neuropharm.2017.02.022","volume":"117","author":"X Hu","year":"2017","unstructured":"Hu X, Song Q, Li X, Li D, Zhang Q, Meng W, Zhao Q (2017) Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson\u2019s model through apoptosis inhibition and autophagy enhancement. Neuropharmacology 117:352\u2013363. doi:\n10.1016\/j.neuropharm.2017.02.022","journal-title":"Neuropharmacology"},{"issue":"27","key":"496_CR16","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278(27):25009\u201325013. doi:\n10.1074\/jbc.M300227200","journal-title":"J Biol Chem"},{"key":"496_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-016-0060-6","volume":"5","author":"Q Hu","year":"2016","unstructured":"Hu Q, Wang G (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. Translational neurodegeneration 5:14. doi:\n10.1186\/s40035-016-0060-6","journal-title":"Translational neurodegeneration"},{"issue":"1","key":"496_CR18","first-page":"9","volume":"51","author":"L Ouyang","year":"2016","unstructured":"Ouyang L, Zhang L, Liu B (2016) Autophagy pathways and key drug targets in Parkinson\u2019s disease. Yao xue xue bao = Acta pharmaceutica Sinica 51(1):9\u201317","journal-title":"Yao xue xue bao = Acta pharmaceutica Sinica"},{"key":"496_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.11.017","author":"K Switon","year":"2016","unstructured":"Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J (2016) Molecular neurobiology of mTOR. Neuroscience. doi:\n10.1016\/j.neuroscience.2016.11.017","journal-title":"Neuroscience"},{"issue":"2","key":"496_CR20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1074\/jbc.270.2.815","volume":"270","author":"CJ Sabers","year":"1995","unstructured":"Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT (1995) Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 270(2):815\u2013822","journal-title":"J Biol Chem"},{"issue":"6","key":"496_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1568007033482652","volume":"2","author":"K Pong","year":"2003","unstructured":"Pong K, Zaleska MM (2003) Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases. Curr Drug Targets CNS Neurol Disord 2(6):349\u2013356","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"3","key":"496_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5114\/fn.2015.54426","volume":"53","author":"K Radad","year":"2015","unstructured":"Radad K, Moldzio R, Rausch WD (2015) Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. Folia Neuropathol 53(3):250\u2013261. doi:\n10.5114\/fn.2015.54426","journal-title":"Folia Neuropathol"},{"issue":"8","key":"496_CR23","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.transproceed.2006.08.037","volume":"38","author":"E Sola","year":"2006","unstructured":"Sola E, Lopez V, Burgos D, Cabello M, Gutierrez C, Martin A, Pena M, Gonzalez-Molina M (2006) Pulmonary toxicity associated with sirolimus treatment in kidney transplantation. Transplant Proc 38(8):2438\u20132440. doi:\n10.1016\/j.transproceed.2006.08.037","journal-title":"Transplant Proc"},{"issue":"4","key":"496_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4065\/79.4.541","volume":"79","author":"NE Vlahakis","year":"2004","unstructured":"Vlahakis NE, Rickman OB, Morgenthaler T (2004) Sirolimus-associated diffuse alveolar hemorrhage. Mayo Clin Proc 79(4):541\u2013545. doi:\n10.4065\/79.4.541","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"496_CR25","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.transproceed.2006.02.123","volume":"38","author":"AA Alkhatib","year":"2006","unstructured":"Alkhatib AA (2006) Sirolimus-induced intractable chronic diarrhea: a case report. Transplant Proc 38(5):1298\u20131300. doi:\n10.1016\/j.transproceed.2006.02.123","journal-title":"Transplant Proc"},{"issue":"3","key":"496_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/01.tp.0000228900.24951.66","volume":"82","author":"JF Altomare","year":"2006","unstructured":"Altomare JF, Smith RE, Potdar S, Mitchell SH (2006) Delayed gastric ulcer healing associated with sirolimus. Transplantation 82(3):437\u2013438. doi:\n10.1097\/01.tp.0000228900.24951.66","journal-title":"Transplantation"},{"issue":"9","key":"496_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrd3802","volume":"11","author":"DC Rubinsztein","year":"2012","unstructured":"Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11(9):709\u2013730. doi:\n10.1038\/nrd3802","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"496_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.exphem.2007.12.008","volume":"36","author":"VY Yazbeck","year":"2008","unstructured":"Yazbeck VY, Buglio D, Georgakis GV, Li Y, Iwado E, Romaguera JE, Kondo S, Younes A (2008) Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. Exp Hematol 36(4):443\u2013450. doi:\n10.1016\/j.exphem.2007.12.008","journal-title":"Exp Hematol"},{"issue":"7","key":"496_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.drudis.2014.02.014","volume":"19","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ, La Spada AR (2014) The many faces of autophagy dysfunction in Huntington\u2019s disease: from mechanism to therapy. Drug Discov Today 19(7):963\u2013971. doi:\n10.1016\/j.drudis.2014.02.014","journal-title":"Drug Discov Today"},{"key":"496_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2014.05.032","volume":"85","author":"T Jiang","year":"2014","unstructured":"Jiang T, Yu JT, Zhu XC, Zhang QQ, Cao L, Wang HF, Tan MS, Gao Q et al (2014) Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance. Neuropharmacology 85:121\u2013130. doi:\n10.1016\/j.neuropharm.2014.05.032","journal-title":"Neuropharmacology"},{"issue":"5","key":"496_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1039\/b804602f","volume":"26","author":"EI Graziani","year":"2009","unstructured":"Graziani EI (2009) Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs. Nat Prod Rep 26(5):602\u2013609. doi:\n10.1039\/b804602f","journal-title":"Nat Prod Rep"},{"issue":"5","key":"496_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.oraloncology.2011.02.020","volume":"47","author":"A Bozec","year":"2011","unstructured":"Bozec A, Etienne-Grimaldi MC, Fischel JL, Sudaka A, Toussan N, Formento P, Milano G (2011) The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab-bevacizumab-irradiation combination on head and neck cancer xenografts. Oral Oncol 47(5):340\u2013344. doi:\n10.1016\/j.oraloncology.2011.02.020","journal-title":"Oral Oncol"},{"issue":"3","key":"496_CR33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","volume":"30","author":"C Malagelada","year":"2010","unstructured":"Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA (2010) Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson\u2019s disease. J Neurosci 30(3):1166\u20131175. doi:\n10.1523\/JNEUROSCI.3944-09.2010","journal-title":"J Neurosci"},{"issue":"8","key":"496_CR34","doi-asserted-by":"publisher","first-page":"e41880","DOI":"10.1371\/journal.pone.0041880","volume":"7","author":"E Esposito","year":"2012","unstructured":"Esposito E, Impellizzeri D, Mazzon E, Paterniti I, Cuzzocrea S (2012) Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson\u2019s disease. PLoS One 7(8):e41880. doi:\n10.1371\/journal.pone.0041880","journal-title":"PLoS One"},{"issue":"5","key":"496_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCRESAHA.107.148338","volume":"101","author":"S Heeneman","year":"2007","unstructured":"Heeneman S, Sluimer JC, Daemen MJ (2007) Angiotensin-converting enzyme and vascular remodeling. Circ Res 101(5):441\u2013454. doi:\n10.1161\/CIRCRESAHA.107.148338","journal-title":"Circ Res"},{"issue":"1","key":"496_CR36","doi-asserted-by":"publisher","first-page":"e29935","DOI":"10.1371\/journal.pone.0029935","volume":"7","author":"KW Lee","year":"2012","unstructured":"Lee KW, Zhao X, Im JY, Grosso H, Jang WH, Chan TW, Sonsalla PK, German DC et al (2012) Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation. PLoS One 7(1):e29935. doi:\n10.1371\/journal.pone.0029935","journal-title":"PLoS One"},{"issue":"3","key":"496_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.mcn.2010.12.011","volume":"46","author":"SM Fleming","year":"2011","unstructured":"Fleming SM, Mulligan CK, Richter F, Mortazavi F, Lemesre V, Frias C, Zhu C, Stewart A et al (2011) A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. Mol Cell Neurosci 46(3):597\u2013606. doi:\n10.1016\/j.mcn.2010.12.011","journal-title":"Mol Cell Neurosci"},{"issue":"1\u20132","key":"496_CR38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02944-4","volume":"918","author":"T Araki","year":"2001","unstructured":"Araki T, Kumagai T, Tanaka K, Matsubara M, Kato H, Itoyama Y, Imai Y (2001) Neuroprotective effect of riluzole in MPTP-treated mice. Brain Res 918(1\u20132):176\u2013181","journal-title":"Brain Res"},{"issue":"2\u20133","key":"496_CR39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","volume":"57","author":"RD Porsolt","year":"1979","unstructured":"Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57(2\u20133):201\u2013210","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"496_CR40","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1038\/npp.2009.118","volume":"34","author":"M Bortolato","year":"2009","unstructured":"Bortolato M, Godar SC, Davarian S, Chen K, Shih JC (2009) Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 34(13):2746\u20132757. doi:\n10.1038\/npp.2009.118","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"496_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14(3):149\u2013167","journal-title":"J Neurosci Methods"},{"issue":"5","key":"496_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1745-7254.2007.00579.x","volume":"28","author":"J Cui","year":"2007","unstructured":"Cui J, Zhang M, Zhang YQ, Xu ZH (2007) JNK pathway: diseases and therapeutic potential. Acta Pharmacol Sin 28(5):601\u2013608. doi:\n10.1111\/j.1745-7254.2007.00579.x","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"496_CR43","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M et al (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol 12(1):25\u201331","journal-title":"Histol Histopathol"},{"issue":"4","key":"496_CR44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4161\/auto.2945","volume":"2","author":"N Mizushima","year":"2006","unstructured":"Mizushima N, Hara T (2006) Intracellular quality control by autophagy: how does autophagy prevent neurodegeneration? Autophagy 2(4):302\u2013304","journal-title":"Autophagy"},{"issue":"4","key":"496_CR45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4161\/auto.2974","volume":"2","author":"M Komatsu","year":"2006","unstructured":"Komatsu M, Kominami E, Tanaka K (2006) Autophagy and neurodegeneration. Autophagy 2(4):315\u2013317","journal-title":"Autophagy"},{"key":"496_CR46","volume-title":"Deconvoluting the complexity of autophagy and Parkinson\u2019s disease for potential therapeutic purpose","author":"J Li","year":"2015","unstructured":"Li J, Li S, Zhang L, Ouyang L, Liu B (2015) Deconvoluting the complexity of autophagy and Parkinson\u2019s disease for potential therapeutic purpose. Oncotarget"},{"key":"496_CR47","doi-asserted-by":"crossref","unstructured":"Siracusa R, Paterniti I, Impellizzeri D, Cordaro M, Crupi R, Navarra M, Cuzzocrea S, Esposito E (2015) The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in Parkinson\u2019s disease model. CNS Neurol Disord Drug Targets","DOI":"10.2174\/1871527314666150821102823"},{"key":"496_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2016.03.016","volume":"65","author":"T Asakawa","year":"2016","unstructured":"Asakawa T, Fang H, Sugiyama K, Nozaki T, Hong Z, Yang Y, Hua F, Ding G et al (2016) Animal behavioral assessments in current research of Parkinson\u2019s disease. Neurosci Biobehav Rev 65:63\u201394. doi:\n10.1016\/j.neubiorev.2016.03.016","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"496_CR49","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nrm2708","volume":"10","author":"H Nakatogawa","year":"2009","unstructured":"Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y (2009) Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 10(7):458\u2013467. doi:\n10.1038\/nrm2708","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"496_CR50","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R et al (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease. PLoS One 5(4):e9979. doi:\n10.1371\/journal.pone.0009979","journal-title":"PLoS One"},{"issue":"11","key":"496_CR51","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1364\/OL.33.001174","volume":"33","author":"CF Hsieh","year":"2008","unstructured":"Hsieh CF, Lai YC, Pan RP, Pan CL (2008) Polarizing terahertz waves with nematic liquid crystals. Opt Lett 33(11):1174\u20131176","journal-title":"Opt Lett"},{"issue":"6","key":"496_CR52","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1083\/jcb.200907014","volume":"186","author":"A Simonsen","year":"2009","unstructured":"Simonsen A, Tooze SA (2009) Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 186(6):773\u2013782. doi:\n10.1083\/jcb.200907014","journal-title":"J Cell Biol"},{"issue":"21","key":"496_CR53","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","volume":"19","author":"Y Kabeya","year":"2000","unstructured":"Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y et al (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19(21):5720\u20135728. doi:\n10.1093\/emboj\/19.21.5720","journal-title":"EMBO J"},{"key":"496_CR54","first-page":"135","volume":"80","author":"M Mogi","year":"1999","unstructured":"Mogi M, Nagatsu T (1999) Neurotrophins and cytokines in Parkinson\u2019s disease. Adv Neurol 80:135\u2013139","journal-title":"Adv Neurol"},{"issue":"8","key":"496_CR55","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1046\/j.1460-9568.2000.00210.x","volume":"12","author":"AR Saha","year":"2000","unstructured":"Saha AR, Ninkina NN, Hanger DP, Anderton BH, Davies AM, Buchman VL (2000) Induction of neuronal death by alpha-synuclein. Eur J Neurosci 12(8):3073\u20133077","journal-title":"Eur J Neurosci"},{"issue":"4","key":"496_CR56","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","volume":"14","author":"OA Levy","year":"2009","unstructured":"Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps. Apoptosis 14(4):478\u2013500. doi:\n10.1007\/s10495-008-0309-3","journal-title":"Apoptosis"},{"issue":"2","key":"496_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2008.04.008","volume":"212","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. Exp Neurol 212(2):235\u2013238. doi:\n10.1016\/j.expneurol.2008.04.008","journal-title":"Exp Neurol"},{"issue":"12","key":"496_CR58","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/01616412.2016.1249997","volume":"38","author":"R Pal","year":"2016","unstructured":"Pal R, Tiwari PC, Nath R, Pant KK (2016) Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson\u2019s disease. Neurol Res 38(12):1111\u20131122. doi:\n10.1080\/01616412.2016.1249997","journal-title":"Neurol Res"},{"key":"496_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbi.2014.06.016","volume":"42","author":"E Russo","year":"2014","unstructured":"Russo E, Andreozzi F, Iuliano R, Dattilo V, Procopio T, Fiume G, Mimmi S, Perrotti N et al (2014) Early molecular and behavioral response to lipopolysaccharide in the WAG\/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT\/mTOR pathways and neuroinflammatory cytokine release. Brain Behav Immun 42:157\u2013168. doi:\n10.1016\/j.bbi.2014.06.016","journal-title":"Brain Behav Immun"},{"issue":"1","key":"496_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12974-017-0793-x","volume":"14","author":"SW Saliba","year":"2017","unstructured":"Saliba SW, Vieira EL, Santos RP, Candelario-Jalil E, Fiebich BL, Vieira LB, Teixeira AL, de Oliveira AC (2017) Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid. J Neuroinflammation 14(1):25. doi:\n10.1186\/s12974-017-0793-x","journal-title":"J Neuroinflammation"},{"key":"496_CR61","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","volume":"107","author":"R Citraro","year":"2016","unstructured":"Citraro R, Leo A, Constanti A, Russo E, De Sarro G (2016) mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis. Pharmacol Res 107:333\u2013343. doi:\n10.1016\/j.phrs.2016.03.039","journal-title":"Pharmacol Res"},{"issue":"5600","key":"496_CR62","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298(5600):1911\u20131912. doi:\n10.1126\/science.1072682","journal-title":"Science"},{"issue":"9","key":"496_CR63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrm906","volume":"3","author":"KA Gallo","year":"2002","unstructured":"Gallo KA, Johnson GL (2002) Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol 3(9):663\u2013672. doi:\n10.1038\/nrm906","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0496-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T04:14:11Z","timestamp":1520309651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0496-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0496-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,29]]}}}